Franklin Resources Inc Horizon Therapeutics Public LTD CO Transaction History

Franklin Resources Inc

$334 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $70.6 Million - $82.6 Million	-713,462 Reduced 29.44%	1,710,251 $198 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $23.6 Million - $27.5 Million	244,781 Added 11.23%	2,423,713 $249 Million
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $109 Million - $115 Million	1,011,135 Added 86.58%	2,178,932 $238 Million
Q4 2022 Feb 10, 2023	SELL	$62.39 - $113.8 $57.8 Million - $105 Million	-926,609 Reduced 44.24%	1,167,797 $133 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $7.9 Million - $11.4 Million	134,053 Added 6.84%	2,094,406 $130 Million
Q2 2022 Aug 11, 2022	SELL	$79.4 - $116.36 $2.87 Million - $4.2 Million	-36,108 Reduced 1.81%	1,960,353 $156 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $2.77 Million - $3.52 Million	32,014 Added 1.63%	1,996,461 $210 Million
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $9.19 Million - $11.2 Million	93,266 Added 4.98%	1,964,447 $212 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $9.35 Million - $11.2 Million	-101,718 Reduced 5.16%	1,871,181 $205 Million
Q2 2021 Aug 13, 2021	SELL	$86.24 - $95.92 $11 Million - $12.3 Million	-128,029 Reduced 6.09%	1,972,899 $185 Million
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $6.43 Million - $8.54 Million	89,493 Added 4.45%	2,100,928 $193 Million
Q4 2020 Feb 10, 2021	BUY	$67.0 - $84.39 $951,333 - $1.2 Million	14,199 Added 0.71%	2,011,435 $147 Million
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $37 Million - $53.6 Million	670,254 Added 50.51%	1,997,236 $155 Million
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $40.1 Million - $75.6 Million	1,326,982 New	1,326,982 $79.7 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account